Method of treating neurodegenerative disorders using epidermal g

Details Method of treating neurodegenerative disorders using epidermal g Method of treating neurodegenerative disorders using epidermal g

1991-04-24

1993-04-06

Moezie, F. T.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514 2, 514 21, A61K 3702, A61K 3736

Patent

active

052003965

ABSTRACT:
Described are pharmaceutical compositions containing neurotrophically effective amount of Epidermal Growth Factor (EGF) as active ingredient together with pharmaceutical excipients and their use in the method of treatment of neurodegenerative disorders, such as Parkinsonism and disorders of traumatic origin.

REFERENCES:
patent: 4861757 (1989-08-01), Antoniades
J. Biol. Chem., vol. 237, No. 5, May 1962, pp. 1555-1562, Cohen, "Isolation of a Mouse Submaxillary Gland Protein . . . ".
J. Biol. Chem., vol. 247, No. 23, 1972, pp. 76097611, Savage et al, "Epidermal Growth Factor and a New Derivative" Levodopa-Merck Index, XI Ed., No. 5344, p. 860.

Affiliated with

Also associated with

Rating

Method of treating neurodegenerative disorders using epidermal g does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of treating neurodegenerative disorders using epidermal g, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating neurodegenerative disorders using epidermal g will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-536766